1. Home
  2. HTLD vs DRUG Comparison

HTLD vs DRUG Comparison

Compare HTLD & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

HOLD

Current Price

$10.88

Market Cap

738.1M

Sector

Industrials

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$82.79

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTLD
DRUG
Founded
1978
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.1M
707.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
HTLD
DRUG
Price
$10.88
$82.79
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$10.00
$124.00
AVG Volume (30 Days)
296.8K
138.6K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
0.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$805,709,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$23.18
52 Week High
$12.13
$123.75

Technical Indicators

Market Signals
Indicator
HTLD
DRUG
Relative Strength Index (RSI) 59.74 61.14
Support Level $10.66 $69.83
Resistance Level $11.54 $84.29
Average True Range (ATR) 0.30 5.07
MACD 0.12 1.79
Stochastic Oscillator 69.47 83.28

Price Performance

Historical Comparison
HTLD
DRUG

About HTLD Heartland Express Inc.

Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: